Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12P - Fermentation or enzyme-using processes to synthesise a desired chemical compound or composition or to separate optical isomers from a racemic mixture › C12P 21 - Preparation of peptides or proteins
Patents for C12P 21 - Preparation of peptides or proteins (112,499)
03/1998
03/24/1998US5730975 Treatment of insulin resistance in obesity linked type II diabetes using antagonist to TNF-alpha function
03/24/1998CA1339776C Equine-gamma-interferon
03/24/1998CA1339775C Antibody 0.5b to hiv-i gp 120 modified with toxic substance
03/24/1998CA1339773C Derivative of adult t cell leukemia virus antigen peptide
03/19/1998WO1998011245A1 Sustained delivery device and methods of making and using the same
03/19/1998WO1998011243A2 Expression of an exogenous gene in a mammalian cell by use of a non-mammalian dna virus having an altered coat protein
03/19/1998WO1998011236A1 Aspartic protease
03/19/1998WO1998011227A1 Granulocyte chemotactic protein 2 variant
03/19/1998WO1998011223A1 Monoclonal antibodies against the extracellular domain of human vegf-receptor protein (kdr)
03/19/1998WO1998011218A1 Cxcr3 chemokine receptor, antibodies, nucleic acids, and methods of use
03/19/1998WO1998011212A1 Ptx sensitive g proteins, the production and use thereof
03/19/1998WO1998011203A1 Cells having dna insertion mutations which produce altered amounts of a polypeptide
03/19/1998WO1998011139A1 Small and intermediate conductance, calcium-activated potassium channels and uses thereof
03/19/1998WO1998011117A1 Cyclitol containing carbohydrates from human tissue which regulate glycogen metabolism
03/19/1998WO1998011116A1 Cyclitol containing carbohydrates from human tissue which regulate lipogenic activity
03/19/1998WO1998010792A1 Immune direction therapy
03/19/1998WO1998010787A2 Pharmaceutical compositions for the treatment of immune disorders
03/19/1998WO1998010652A1 NOVEL trpS
03/19/1998CA2265933A1 Sustained delivery device and methods of making and using the same
03/19/1998CA2265927A1 Monoclonal antibodies against the extracellular domain of human vegf-receptor protein (kdr)
03/19/1998CA2265885A1 Pharmaceutical compositions for the treatment of immune disorders
03/19/1998CA2265467A1 Ptx sensitive g proteins, the production and use thereof
03/19/1998CA2265455A1 Granulocyte chemotactic protein 2 variant
03/19/1998CA2264966A1 Expression of an exogenous gene in a mammalian cell by use of a non-mammalian dna virus having an altered coat protein
03/19/1998CA2264938A1 Cyclitol containing carbohydrates from human tissue which regulate lipogenic activity
03/19/1998CA2264825A1 Cyclitol containing carbohydrates from human tissue which regulate glycogen metabolism
03/18/1998EP0828847A1 Enzyme catalysis in organic solutions
03/18/1998EP0828844A1 Promoters for gene expression
03/18/1998EP0828843A1 Recombinant heregulins and their biological functions upon receptor activation
03/18/1998EP0828842A1 Novel fusion protein recovery and purification methods
03/18/1998EP0828833A1 Chemokine n-terminal deletion mutations
03/18/1998EP0828832A2 $g(D)P62, ITS VARIANTS, NUCLEIC ACID SEQUENCES ENCODING THEM, AND THEIR USES IN ANTI-CANCER GENE THERAPY
03/18/1998EP0828831A2 A novel human purinergic p 2u? receptor
03/18/1998EP0828830A1 Eb1 gene product binds to apc
03/18/1998EP0828829A1 A gene switch comprising an ecdysone receptor
03/18/1998EP0828828A2 C-C CHEMOKINE RECEPTOR 3: CKP-3 OR Eos-L2
03/18/1998EP0828826A1 Plant promoter activated by fungal infection
03/18/1998EP0828759A1 Process of high purity albumin production
03/18/1998EP0828757A1 Helicobacter pylori antigens and vaccine compositions
03/18/1998EP0828756A2 Diagnosis of, and vaccination against, a positive stranded rna virus using an isolated, unprocessed polypeptide
03/18/1998EP0828519A1 Recombinant viral vector system
03/18/1998EP0828510A1 Abundant extracellular products and methods for their production and use
03/18/1998EP0688431A4 Method for screening catalytic non-enzyme polypeptides and proteins
03/18/1998CN1176659A A method for making heteromultimeric polypeptides
03/18/1998CN1176658A Vaccine and antitoxin for treatment and prevention of C. difficile disease
03/18/1998CN1176603A Vascular endothelial growth factor-B
03/18/1998CN1176391A Monoclonal antibodies against human interleukin-4 and hybridowas producing the same
03/18/1998CN1176307A Preparation of selenic antibody enzyme with activity higher than that of natural enzyme
03/18/1998CN1176061A Process for preparing protein hydrolysate from protein-containing animal products
03/17/1998US5728925 Chimaeric gene coding for a transit peptide and a heterologous polypeptide
03/17/1998US5728821 Mutant BR96 antibodies reactive with human carcinomas
03/17/1998US5728819 Secreted proteins and polynucleotides encoding them
03/17/1998US5728817 Methods and compositions for controlling plant development
03/17/1998US5728815 Bone and prostate-derived protein factors affecting prostate cancer growth, differentiation, and metastasis
03/17/1998US5728814 Monoclonal antibodies, hybridoma cell line
03/17/1998US5728813 Antibodies directed against elk ligand
03/17/1998US5728808 Human Prostaglandin receptor IP
03/17/1998US5728806 TIH1, protein that interacts with casein kinase I
03/17/1998US5728803 Pantropic neurotrophic factors
03/17/1998US5728679 BMP-15 compositions
03/17/1998US5728677 Administering a specified polypeptide to a mammal
03/17/1998US5728674 Polypeptides as anticoagulants
03/17/1998US5728590 Small organometallic probes
03/17/1998US5728578 Peptide of the structural phosphoprotein (pp 150) of human cytomegalovirus, and DNA encoding said peptide
03/17/1998US5728561 Genes encoding branched-chain alpha-ketoacid dehydrogenase complex from Streptomyces avermitilis
03/17/1998US5728555 Preparation of d-amino acids by direct fermentative means
03/17/1998US5728553 High purity albumin and method of producing
03/17/1998US5728549 Gene expression vectors with controlling sequences of dna
03/17/1998US5728547 Vectors for use in filamentous fungi
03/17/1998US5728545 Cloning and recombinant production of CRF receptor (S)
03/17/1998US5728544 Useful in synthesis of aspartame intermediate
03/17/1998US5728543 Clostripain catalyzed hydrolysis of preproinsulin analogs into corresponding insulins
03/17/1998US5728537 Antigen immunogens for cancer detection in epithelial fluids
03/17/1998US5728536 Jak kinases and regulation of Cytokine signal transduction
03/17/1998US5728520 Immunoreactive polypeptide compositions
03/17/1998US5728387 Structural gene of pneumococcal protein
03/17/1998CA1339758C Human reg protein
03/17/1998CA1339757C Production of purified biologically active, bacterially produced recombinant human csf-1
03/17/1998CA1339737C Fibrin-specific and fibrinogen-specific monoclonal antibodies and their derivation from immunized germ free mice
03/17/1998CA1339735C Cloning and sequencing of the major outer capsid gylcoprotein gene of a human rotavirus
03/17/1998CA1339732C Synthesis and immunogenicity of rotavirus genes using baculovirus expression system
03/17/1998CA1339730C Monoclonal antibiodies and methods for fungal pathogen detection
03/12/1998WO1998010081A2 Improved barstar-gene
03/12/1998WO1998010070A1 HUMANIZED IMMUNOGLOBULIN REACTING SPECIFICALLY WITH Fas LIGAND OR ACTIVE FRAGMENTS THEREOF AND REGION INDUCING APOPTOSIS ORIGINATING IN Fas LIGAND
03/12/1998WO1998010068A2 Methods and reagents for discovering and using mammalian melanocortin receptor agonists and antagonists to modulate feeding behavior in animals
03/12/1998WO1998010066A1 Modulators of brca1 activity
03/12/1998WO1998010063A1 Methods for preparing synthetic repetitive dna
03/12/1998WO1998009649A1 Inhibition of viral replication
03/12/1998WO1998009646A1 A method for generating birnavirus from synthetic rna transcripts
03/12/1998WO1998009639A1 Novel bacteriocins, transport and vector system and method of use thereof
03/12/1998WO1998009505A1 Plant retroviral polynucleotides and methods for use thereof
03/12/1998WO1998004709A3 Herpes simplex virus ICP4 is an inhibitor of apoptosis
03/12/1998WO1997046682A3 Polynucleotides from human adult PBMC encoding secreted proteins
03/12/1998WO1997046259A3 Chimeric toxin for targeted therapy
03/12/1998WO1997038087A3 Alphaviral vector with reduced inhibition of cellular macromolecular synthesis
03/12/1998DE19638745A1 Monoklonale Antikörper gegen die extrazelluläre Domäne des menschlichen VEGF - Rezeptorproteins (KDR) Monoclonal antibodies against the extracellular domain of the human VEGF - receptor protein (KDR)
03/12/1998CA2264968A1 Humanized immunoglobulin reacting specifically with fas ligand or active fragments thereof and region inducing apoptosis originating in fas ligand
03/12/1998CA2264965A1 Methods and reagents for discovering and using mammalian melanocortin receptor agonists and antagonists to modulate feeding behavior in animals
03/12/1998CA2264845A1 Novel bacteriocins, transport and vector system and method of use thereof
03/12/1998CA2264489A1 Plant retroviral polynucleotides and methods for use thereof
1 ... 876 877 878 879 880 881 882 883 884 885 886 887 888 889 890 891 892 893 894 895 896 ... 1125